APA (7th ed.) Citation

Ruhwedel, T., Rogasch, J., Galler, M., Schatka, I., Wetz, C., Furth, C., . . . Beetz, N. L. (2025). AI-driven body composition monitoring and its prognostic role in mCRPC undergoing lutetium-177 PSMA radioligand therapy: Insights from a retrospective single-center analysis. EJNMMI Research, 15(1), 1. https://doi.org/10.1186/s13550-025-01312-9

Chicago Style (17th ed.) Citation

Ruhwedel, Tristan, et al. "AI-driven Body Composition Monitoring and Its Prognostic Role in MCRPC Undergoing Lutetium-177 PSMA Radioligand Therapy: Insights from a Retrospective Single-center Analysis." EJNMMI Research 15, no. 1 (2025): 1. https://doi.org/10.1186/s13550-025-01312-9.

MLA (9th ed.) Citation

Ruhwedel, Tristan, et al. "AI-driven Body Composition Monitoring and Its Prognostic Role in MCRPC Undergoing Lutetium-177 PSMA Radioligand Therapy: Insights from a Retrospective Single-center Analysis." EJNMMI Research, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1186/s13550-025-01312-9.